Receives
-
Biologics
Alafair Biosciences Receives Innovative Technology Contract from Vizient for VersaWrap®
Contract awarded for products that bring improvement to healthcare industry AUSTIN, Texas, April 3, 2024 /PRNewswire/ — Alafair Biosciences, Inc., a leading innovator…
Read More » -
Recon
94-Year-Old, Orthopaedic Surgeon William H. Harris, M.D., World-Renowned Medical Pioneer, Inventor, Mentor, Receives Lifetime Achievement Award
William H. Harris, M.D., to be Honored for His Six-Decade-Long Career in Orthopaedics and Transformative Contributions in the Field of…
Read More » -
Biologics
BONESUPPORT™ Founder Lars Lidgren Receives the 2017 OREF Clinical Research Kappa Delta Award
Lund, Sweden, 16 March, 2017 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone…
Read More » -
Recon
Summit Orthopedics’ Vadnais Heights Surgery Center Receives The Joint Commission’s Advanced Certification
WOODBURY, Minn., March 6, 2017 /PRNewswire/ — Summit Orthopedics is to pleased to announce that its Vadnais Heights Surgery Center has…
Read More » -
Hospitals
7D Surgical Receives FDA 510(K) and Health Canada MDL Clearance for Its Breakthrough Image Guidance System for Spine Surgery
TORONTO, Jan. 23, 2017 /PRNewswire/ — 7D Surgical announced today that it has received both 510(k) clearance from the U.S. Food and…
Read More » -
Hospitals
Osseon Receives New Patent
SANTA ROSA, Calif., Jan. 12, 2017 /PRNewswire/ — Osseon announced today that the company has received a new patent for a Steerable and…
Read More » -
Hospitals
Orthofix Receives FDA and CE Mark Approvals for New Bone Growth Stimulators
January 09, 2017 08:00 AM Eastern Standard Time LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical device company,…
Read More » -
Biologics
MiMedx EpiFix Receives Coverage From Aetna
MARIETTA, Ga., Dec. 27, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected…
Read More » -
Hospitals
Vivex Biomedical, Inc. Receives Level II HCPCS Q-Code for Cygnus™, a Human Amniotic Tissue Allograft
ATLANTA Dec. 20, 2016 /PRNewswire Vivex Biomedical, Inc. (Vivex) is a biomaterials developer focused on creating treatment options and creative…
Read More »